← Other psychedelics

2C-E

4-Ethyl-2,5-dimethoxyphenethylamine

A long-lasting member of the 2C family, often described as deeply absorbing.

C₁₂H₁₉NO₂View molecular structure

2C-E is a synthetic psychedelic documented by Alexander and Ann Shulgin. Its name resembles 2C-B, but it should be treated as a distinct compound.

Most descriptions of its human effects come from firsthand accounts rather than large controlled studies.

2C-E at a glance

Family
Phenethylamines · 2C family
Type
Serotonergic psychedelic
Primary target
5-HT2A
Onset (oral)
Variable; limited controlled data
Duration (oral)
Reported 8–12 hours
Origin
Synthetic

What is 2C-E?

2C-E is a substituted phenethylamine. Like other serotonergic psychedelics, its activity involves 5-HT2A receptors, although a receptor label does not describe the whole subjective experience.

The E refers to an ethyl group in the molecule. Small structural changes within the 2C family can produce important differences in effect and duration.

The 2C-E experience

Sensory effects

Published personal accounts describe pronounced visual patterns and altered spatial perception. These observations come mainly from reports rather than controlled human studies.

Sound may feature in sensory accounts, but direct evidence is too limited to define a distinctive auditory effect.

Body sensations

Physical discomfort can be prominent in reports. The long duration may make tension or other unpleasant sensations particularly demanding.

Headspace

Sustained introspection is a recurring theme. Some accounts emphasise emotional depth; others describe a more detached or analytical quality. These conflicting descriptions show why a compound should not be given a fixed experiential personality.

Self, time and space

Space and the passage of time may feel substantially altered. Changes in self-awareness are reported, but their frequency and character are not well quantified.

History and culture

2C-E became known through Shulgin’s exploration of phenethylamines and the publication of PiHKAL. Online communities later contributed further reports and comparisons.

That record is valuable cultural documentation, but it was not collected with the controls or representative sampling of a clinical study.

Research and uses

Research on related receptors and chemical families provides a framework for understanding 2C-E. Direct human research is much more limited.

There is no strong clinical basis for presenting it as a treatment. Reports of insight or personal change are starting points for questions, rather than proof of medical benefit.

Risks and considerations

Severe adverse reactions have been associated with 2C-family compounds, and long-term evidence is limited. Psychological distress, cardiovascular effects and uncertain product identity are important considerations.

Its similarity in name to 2C-B can be misleading. Expectations or assumptions transferred from another compound may not apply.

FAQ

Is 2C-E simply a longer version of 2C-B?

No. They are different molecules; duration is only one difference.

Where does the duration estimate come from?

It is reported in early human accounts, including PiHKAL, rather than established by large clinical trials.

Is an intense experience necessarily beneficial?

No. Intensity does not establish insight, healing or lasting benefit.

Sources
  1. Shulgin and Shulgin: PiHKAL, 2C-E
  2. Receptor activity of 2C and NBOMe compounds
  3. PubChem: 2C-E molecular identity